Latest filing published 01 Oct 2026 for RESMED INC.
Filing timeline
BuySaleInsider track record
Justin Leong: trading record in brief
All filings by Justin Leong on record concern ResMed Inc, in the capacity of chief executive. Over a trading history stretching from 5 November 2020 to 14 August 2026, the count stands at 24 filings.
Sales make up the whole of the open-market record (4 sales, €13.2M). The rest of the record consists of 18 share grants and 2 option exercises.
On 1 October 2026 came the latest disclosure, a share grant in ResMed Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Justin Leong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,461 shares0ResMed Common StockSEC:0000943819-26-000077:0
- 1,848 shares0ReMed Common StockSEC:0000943819-25-000179:0
- 5,462 shares0ReMed Common StockSEC:0000943819-25-000041:0
- 6,160 shares@ US$243.08710.1% of flowReMed Common StockSEC:0001127602-24-027960:0
- 8,259 shares0ReMed Common StockSEC:0001127602-24-022299:0
- 48,000 shares@ US$217.07467.3% of flowReMed Common StockSEC:0001127602-24-021754:0
- 15,000 shares@ US$57.766.0% of flowReMed Common StockSEC:0001127602-22-026349:0
- 9,162 shares@ US$254.810.0074% mcap15.9% of flowReMed Common StockSEC:0001127602-22-000624:0
- 1,339 shares@ US$254.812.1% of flowReMed Common StockSEC:0001127602-21-029802:0
- 9,162 shares@ US$254.810.0074% mcap15.9% of flowReMed Common StockSEC:0001127602-21-029581:0
- 9,162 shares@ US$254.8114.5% of flowReMed Common StockSEC:0001127602-21-029616:0
- 2,631 shares0ReMed Common StockSEC:0001127602-21-024090:0
12 of 12 declarations
